2,450 Danaher Corporation $DHR Shares Purchased by Trek Financial LLC

Trek Financial LLC boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 23.9% during the third quarter, HoldingsChannel.com reports. The firm owned 12,701 shares of the conglomerate’s stock after acquiring an additional 2,450 shares during the period. Trek Financial LLC’s holdings in Danaher were worth $2,814,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Prime Capital Investment Advisors LLC boosted its stake in shares of Danaher by 0.5% during the 3rd quarter. Prime Capital Investment Advisors LLC now owns 9,203 shares of the conglomerate’s stock valued at $2,039,000 after buying an additional 45 shares during the period. Essential Investment Partners LLC increased its stake in shares of Danaher by 34.6% in the third quarter. Essential Investment Partners LLC now owns 175 shares of the conglomerate’s stock worth $39,000 after acquiring an additional 45 shares during the last quarter. Veery Capital LLC increased its stake in shares of Danaher by 3.1% in the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock worth $350,000 after acquiring an additional 48 shares during the last quarter. Studio Investment Management LLC raised its holdings in shares of Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after acquiring an additional 51 shares in the last quarter. Finally, Meridian Financial Partners LLC raised its holdings in shares of Danaher by 1.2% during the third quarter. Meridian Financial Partners LLC now owns 4,636 shares of the conglomerate’s stock worth $1,073,000 after acquiring an additional 56 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $275.00 price target on shares of Danaher in a research note on Thursday, October 22nd. Morgan Stanley lifted their price target on Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday, October 12th. DZ Bank cut Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Finally, Robert W. Baird boosted their price target on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.

Danaher Stock Down 1.8%

DHR stock opened at $228.04 on Tuesday. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a fifty day simple moving average of $219.09 and a 200 day simple moving average of $201.73. The firm has a market cap of $160.44 billion, a PE ratio of 37.32, a PEG ratio of 2.94 and a beta of 0.76.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The firm had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same period in the prior year, the business posted $1.89 earnings per share. The business’s quarterly revenue was up 8.3% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s dividend payout ratio is 26.19%.

Insider Activity at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 10.80% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.